Membrane transporters in drug development and as determinants of precision medicine. Read more about Membrane transporters in drug development and as determinants of precision medicine.
Extracellular targeted protein degradation: an emerging modality for drug discovery. Read more about Extracellular targeted protein degradation: an emerging modality for drug discovery.
Author Correction: RAS-targeted therapies: is the undruggable drugged? Read more about Author Correction: RAS-targeted therapies: is the undruggable drugged?
RAS-targeted therapies: is the undruggable drugged? Read more about RAS-targeted therapies: is the undruggable drugged?
Synthetic lethality as an engine for cancer drug target discovery. Read more about Synthetic lethality as an engine for cancer drug target discovery.
Next-generation regulatory T cell therapy. Read more about Next-generation regulatory T cell therapy.
Prospects for pharmacological targeting of pseudokinases. Read more about Prospects for pharmacological targeting of pseudokinases.
Unexplored therapeutic opportunities in the human genome. Read more about Unexplored therapeutic opportunities in the human genome.
Unexplored therapeutic opportunities in the human genome. Read more about Unexplored therapeutic opportunities in the human genome.
